Global Intravenous Immunoglobulin (IVIg) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch's in-depth investigation and research, the global Intravenous Immunoglobulin (IVIg) market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Intravenous Immunoglobulin (IVIg) market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Intravenous Immunoglobulin (IVIg) is a therapeutic preparation consisting of concentrated antibodies derived from pooled human plasma. Administered intravenously, IVIg is used to boost the immune system and treat various medical conditions related to immune deficiencies, autoimmune disorders, and certain neurological diseases. The antibodies in IVIg provide passive immunity by supplying the recipient with a diverse range of antibodies against a variety of pathogens. This therapy is employed in the management of conditions such as primary immunodeficiency disorders, autoimmune diseases like rheumatoid arthritis and lupus, and neurological disorders such as Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP). IVIg is carefully processed to remove potential contaminants and is administered under medical supervision due to the risk of side effects. The therapeutic use of IVIg underscores its role in modulating the immune response and addressing a spectrum of immune-related disorders.

The major global  manufacturers of Intravenous Immunoglobulin (IVIg) include Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Intravenous Immunoglobulin (IVIg). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Intravenous Immunoglobulin (IVIg) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Intravenous Immunoglobulin (IVIg) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Intravenous Immunoglobulin (IVIg) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Intravenous Immunoglobulin (IVIg) Include:

Baxter

Grifols

CSL

Octapharma

Biotest

Kedrion

Hualan Bio

CNBG

Shanghai RAAS

CBPO

LFB Group

BPL

Sichuan Yuanda Shuyang

Intravenous Immunoglobulin (IVIg) Product Segment Include:

IVIg Liquid

IVIg Powder

Intravenous Immunoglobulin (IVIg) Product Application Include:

Immunodeficiency

Autoimmune Disease

Acute Infection

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Intravenous Immunoglobulin (IVIg) Industry PESTEL Analysis

Chapter 3: Global Intravenous Immunoglobulin (IVIg) Industry Porter's Five Forces Analysis

Chapter 4: Global Intravenous Immunoglobulin (IVIg) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 5: Global Intravenous Immunoglobulin (IVIg) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 6: Global Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Forecast by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 8: Industrial Chain Analysis, Intravenous Immunoglobulin (IVIg) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources